Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03303846 · ClinicalTrials.gov registry record · NA

Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients

A NA study of Healthy Subject, sponsored by City of Hope Medical Center.

Active
Registry status
NA
Development phase
344
Enrollment target
5
Study locations

NCT03303846 is a NA study of Healthy Subject that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 344 participants, above the 227-participant average among 16 other Healthy Subject trials with a reported enrollment target (52% higher). The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03303846, a NA study of Healthy Subject, is active but no longer recruiting, sponsored by City of Hope Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
344 participants
Enrollment target
5
Study locations

Study Summary

This clinical trial studies normal breast tissue changes combined with breast magnetic resonance imaging (MRI) that may suggest the beginnings of cancer development. Using breast tissue markers in combination with breast imaging such as MRI may help to more accurately assess a woman's risk of developing breast cancer.

Conditions Studied

Interventions

  • PROCEDURE Biospecimen Collection
  • PROCEDURE Magnetic Resonance Imaging
  • OTHER Laboratory Biomarker Analysis

Study Locations (5)

California

  • City of Hope Medical Center - Duarte
  • University of Southern California - Los Angeles

North Carolina

  • Duke University - Durham

Ohio

  • Ohio State University, Stefanie Spielman Comprehensive Breast Center - Columbus

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 344 participants
Start Date 2017-10-13
Est. Completion 2026-04-25
Phase NA

Sponsor

City of Hope Medical Center

582 total trials

What the Registry Record Tells You About NCT03303846

The ClinicalTrials.gov registry entry for NCT03303846 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 344 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 227-participant average among 16 other Healthy Subject trials with a reported enrollment target (52% higher). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy Subject appearing as the primary indexed condition, and to 3 interventions - of which Biospecimen Collection is the first listed.

NCT03303846 reports 5 study locations spanning 4 distinct geographic areas - top geographies include California, North Carolina, Ohio.

Frequently Asked Questions

What is clinical trial NCT03303846 about?

NCT03303846 is a clinical study titled "Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients". This clinical trial studies normal breast tissue changes combined with breast magnetic resonance imaging (MRI) that may suggest the beginnings of cancer development. Using breast tissue markers in combination with breast imaging such as MRI may help to more accurately assess a woman's risk of develo...

What is the current status of trial NCT03303846?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 344 participants. The study started on 2017-10-13. Estimated completion is 2026-04-25.

What conditions does trial NCT03303846 study?

This clinical trial studies the following conditions: Healthy Subject.

What interventions are being tested in trial NCT03303846?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Magnetic Resonance Imaging (PROCEDURE), Laboratory Biomarker Analysis (OTHER).

Who is sponsoring clinical trial NCT03303846?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03303846 being conducted?

This trial has 5 study locations across California, North Carolina, Ohio, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Subject

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.